MedTrace Logo

The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy

NCT02271555 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2014-10-22

No results posted yet for this study

Summary

The investigators will be evaluated the effects of a single loading dose of remifentanil (1µg/kg), administered as an adjunct to sevoflurane, on duration of hemodynamic profile, seizure activity, and recovery times during electroconvulsive therapy (ECT) in patients with major depression

Conditions

  • Haemodynamic Rebound

Interventions

DRUG

Sevoflurane

Anesthetic induction will be achieved via 8% sevoflurane

DRUG

Remifentanil

After the loss of consciousness remifentanil will be administered to Group sevoflurane-remifentanil in the form of a 1 µg/kg intravenous bolus.

DRUG

Saline

After the loss of consciousness saline will be administered to Group sevoflurane-saline intravenous bolus.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Feray Erdil, MD · İnonu Univercity Medical Faculty Department of Anestheisology and Reanimation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271555 on ClinicalTrials.gov